Guggenheim analyst, John Heinbockel, reiterated his Buy rating on shares of CVS Health (NYSE: CVS) after media reports state the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE